Outcome of Board Meeting

F.BSE-NSE/QPA/0249 11th August, 2026 Listing Department Listing Department BSE Limited National Stock Exchange of India Limited Phiroze Jeejeebhoy Towers, Exchange Plaza, Plot No. C/1, G. Block Dalal Street, Mumbai- 400001 Bandra Kurla Complex, Bandra (E) Mumbai- 400051 REF: SCRIP CODE: 532935/ARIES SUB: OUT COME OF THE BOARD MEETING HELD ON 11.08.2026 Dear Sir, Pursuant to Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 (Listing Regulations), please note the following Out Come of the Meeting of the Board of Directors of the Company held on 11th August, 2026: 1. The Board approved Un-Audited Financial Results (both Standalone and Consolidated) of the Company for the First Quarter ended 30th June, 2026 as required under the Listing Regulations. 2. The Board has also decided to convene the Annual General Meeting of the Company on Tuesday, 29th September, 2026 and has approved the draft Notice and Explanatory Statement, in this respect. 3. The Board has fixed Tuesday, 22nd September, 2026 as the CUT OFF/RECORD DATE for the purpose of determining the entitlement of the Equity Shareholders for the Dividend-2025-26. 4. The Board has fixed Payment Date for the Dividend-2025-26 on or before Friday, 23rd October, 2026. 5. The Board upon recommendation of Nomination and Remuneration Committee and Audit Committee approved re-appointment of Dr. Rahul Mirchandani (DIN: 00239057), as Managing Director of the Company for a period of 5(Five) years w.e.f. 1st April, 2027 subject to the approval of Members by passing a Special Resolution at the ensuing Annual General Meeting. 6. The Board upon recommendation of Nomination and Remuneration Committee has re- appointed Mr. Nrupang Bhumitra Dholakia (DIN: 06522711), as an Independent Director of the Company, not liable to retire by rotation and to hold the office for second term of 5 (five) consecutive years on the Board of the Company with effect from 15th March, 2027 upto 14th March, 2032 subject to the approval of Members by passing a Special Resolution at the ensuing Annual General Meeting. The information required to be disclosed pursuant to Regulation 30 of Listing Regulations read with Circular No. HO/49/14/14(7)2025-CFD POD2/I/3762/2026 dated January 30, 2026 is enclosed as “Annexure A” AN ISO 9001 COMPANY : Quality Management System: ISO 9001: 2015 Certified Regd. Office : Aries House, Plot No. 24, Deonar, Govandi (E), Mumbai 400 043. CIN : L99999MH1969PLC014465 Phone : + 91 22 2552 9000, 2556 4052 /53 Fax : + 91 22 2556 4054, 2557 1711 Email : ariesagro@ariesagro.com Website : www.ariesagro.com DECLARATIONS: 1. We declare that Dr. Rahul Mirchandani and Mr. Nrupang Bhumitra Dholakia are not debarred for appointment as a Director by any Order of SEBI or other Authorities. 2. Mr. Nrupang Bhumitra Dholakia is not related to any Director of the Company. We are enclosing herewith following: 1. Un-Audited Financial Results (both Standalone and Consolidated) for the First Quarter ended 30th June, 2026. 2. Limited Review Report by Statutory Auditors. 3. Brief Profile of Dr. Rahul Mirchandani and Mr. Nrupang Bhumitra Dholakia is enclosed as in “Annexure A”. The Board Meeting started at 2.27 p.m. and concluded at 4.15 p.m. Kindly take the same on your records. Thanking you, Yours faithfully For Aries Agro Limited Qaiser P. Ansari Company Secretary & Compliance Officer Encl: a/a. AN ISO 9001 COMPANY : Quality Management System: ISO 9001: 2015 Certified Regd. Office : Aries House, Plot No. 24, Deonar, Govandi (E), Mumbai 400 043. CIN : L99999MH1969PLC014465 Phone : + 91 22 2552 9000, 2556 4052 /53 Fax : + 91 22 2556 4054, 2557 1711 Email : ariesagro@ariesagro.com Website : www.ariesagro.com ARIES AGRO LIMITED Registered Office: Aries House, Plot No. 36 (Old Plot No. 24), Deonar, Govandi (E), Mumbai - 400 043. CIN - L99999MH1969PLC014465 PART I - STATEMENT OF UN-AUDITED FINANCIAL RESULTS FOR THE QUARTER ENDED JUNE 30, 2026 Rupees in Lakhs (Except EPS) Rupees in Lakhs (Except EPS) Consolidated Financial Results Standalone Financial Results Three Months Ended Preceeding Three Corresponding Three Accounting Year Three Months Preceeding Three Corresponding Three Accounting Year Months Ended Months Ended in the Ended Ended Months Ended Months Ended in the Ended Sr No Particulars Previous Year Previous Year 30-Jun-26 31-Mar-26 30-Jun-25 31-Mar-26 30-Jun-26 31-Mar-26 30-Jun-25 31-Mar-26 ( UN-AUDITED ) ( AUDITED ) ( UN-AUDITED ) ( AUDITED ) ( UN-AUDITED ) ( AUDITED ) ( UN-AUDITED ) ( AUDITED ) 1 Income from Operations a) Revenue from Operations 23,705.65 24,280.93 20,477.99 95,688.23 23,194.23 23,448.62 19,894.91 91,764.02 Less :- Discounts / Rebates 5,119.89 6,359.16 4,499.21 21,682.55 5,111.52 6,370.80 4,475.58 21,581.11 Net Income from Operations 18,585.77 17,921.77 15,978.78 74,005.68 18,082.71 17,077.83 15,419.33 70,182.91 b) Other Operating Income 172.72 558.08 136.76 1,270.94 252.04 627.35 202.26 1,608.33 Total Income from Operations (net) 18,758.48 1 8,479.85 16,115.54 75,276.62 1 8,334.74 17,705.17 15,621.59 71,791.24 2 Expenses a) Consumption of Materials / Rebranded Goods 4,936.53 5,957.05 3,739.02 24,714.53 4,531.04 6,602.57 3,828.27 25,747.68 b) Cost of Products Traded 4,626.55 5,736.91 3,997.75 15,682.00 4,742.33 4,793.96 3,855.12 13,622.73 c) Changes in Inventories of Finished Goods and Work in Progress (12.87) (720.15) 588.87 (1,302.78) 318.81 (803.82) 512.46 (1,513.98) d) Employee Benefits Expense 2,061.44 2,305.26 1,718.58 7,914.82 2,000.27 2,317.79 1,662.54 7,761.82 e) Finance Costs 482.63 337.45 483.77 1,771.85 446.73 302.54 464.96 1,661.82 f) Depreciation & Amortisation Expense 266.42 303.28 248.38 1,085.14 234.23 252.53 224.11 958.81 g) Manufacturing Expenses 1,203.80 1,488.20 944.83 5,018.61 1,087.99 1,254.68 862.00 4,479.08 h) Selling & Distribution Expenses 2,694.00 3,079.74 2,485.36 12,345.13 2,638.30 2,852.48 2,399.36 11,848.34 i) Administration & Other Expenses 537.63 601.85 459.70 2,018.52 525.79 536.68 443.48 1,879.62 Total Expenses 1 6,796.15 1 9,089.59 1 4,666.27 6 9,247.82 1 6,525.48 1 8,109.40 1 4,252.30 6 6,445.91 3 Profit / ( Loss ) from Operations before Exceptional Items (1 - 2 ) 1 ,962.33 ( 609.74) 1 ,449.27 6 ,028.80 1 ,809.26 ( 404.23) 1 ,369.29 5 ,345.33 4 Exceptional Items - - - - - - - - 5 Profit / ( Loss ) for the period ( 3 + 4 ) 1 ,962.33 ( 609.74) 1 ,449.27 6 ,028.80 1 ,809.26 ( 404.23) 1 ,369.29 5 ,345.33 6 Tax Expense (a) Current Tax 503.00 (73.41) 455.65 1,662.24 452.00 (87.00) 428.00 1,476.00 (b) Mat Credit Entitlement - (12.24) (27.65) (175.24) - - - - (c) Adjustment of Tax relating to Earlier Year - 28.48 (6.78) 36.75 - 36.54 - 38.04 (d) Deferred Tax (25.20) (73.79) 35.05 268.05 (4.81) (5.88) 24.26 (5.85) Total Tax Expenses 4 77.80 ( 130.96) 4 56.27 1 ,791.80 4 47.19 ( 56.34) 4 52.26 1 ,508.18 Net Profit / (Loss) for the period ( 5 - 6 ) 1 ,484.54 ( 478.78) 9 93.01 4 ,237.00 1 ,362.07 ( 347.89) 9 17.03 3 ,837.15 Share of Profit / (Loss ) of Associates and Joint Ventures accounted for using equity method - - - - - - - - Net Profit / (Loss) for the period ( 7 + 8 ) 1 ,484.54 ( 478.78) 9 93.01 4 ,237.00 1 ,362.07 ( 347.89) 9 17.03 3 ,837.15 10 Other Comprehensive Income / Loss (A) Items that will not be reclassified to Profit or Loss (i) Changes in Revaluation Surplus - - - - - - - - (ii) Remeasurements of Defined Benefit Plans ( 78.52) 7 6.82 2 1.68 9 2.85 ( 78.52) 7 6.82 2 1.68 9 2.85 (iii) Equity Instruments through OCI - - - - - - - - ( 78.52) 7 6.82 2 1.68 9 2.85 ( 78.52) 7 6.82 2 1.68 9 2.85 (iv) Less :- Income Tax relating to Items that will not be reclassified to Profit or Loss ( 4.79) 5 .93 5 .91 8 .01 ( 4.79) 5 .93 5 .91 8 .01 ( 73.73) 7 0.89 1 5.77 8 4.83 ( 73.73) 7 0.89 1 5.77 8 4.83 (B)Items that will be reclassified to Profit or Loss (i) Exchange Differences in translating the Financial Statements of Foreign Operation ( 0.24) ( 16.69) ( 0.17) ( 19.13) - - - - (ii) Debt Instruments throug [Showing first 8,000 characters — download PDF for full document]